BIORESORBABLE IMPLANTS MARKET ANALYSIS

Bioresorbable Implants Market, By Material Type (Metallic and Polymer), By Application (Orthopedic, Cardiovascular, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In March 2023, Bioretec Ltd, a medical device company, received FDA market authorization for its RemeOs trauma screw, marking a milestone as the first and only company offering bioresorbable metal implants in the U.S. This innovation aims to replace traditional titanium and steel implants used in healing bone fractures, eliminating the need for removal surgeries.
In 2021, DePuy Synthes, a division of Johnson & Johnson, acquired OrthoSpin via its Synthes GmbH subsidiary. OrthoSpin, an Israeli firm, specializes in developing a robotic-assisted external fixation system for orthopedic treatments.
In 2020, Medtronic, a global leader in medical technology, services, and solutions introduced the Adaptix Interbody System, featuring Titan nanoLOCK Surface Technology, as the first guided titanium implant available in the U.S. This innovative product has significantly enhanced Medtronic's market presence and revenue in the region.